BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35907102)

  • 1. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
    Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
    Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study.
    Singh AG; Crowson CS; Singh S; Denis M; Davis P; Maradit-Kremers H; Matteson EL; Chowdhary VR
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1664-1670. PubMed ID: 27015109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    Yafasova A; Fosbøl EL; Schou M; Baslund B; Faurschou M; Docherty KF; Jhund PS; McMurray JJV; Sun G; Kristensen SL; Torp-Pedersen C; Køber L; Butt JH
    J Am Coll Cardiol; 2021 Apr; 77(14):1717-1727. PubMed ID: 33832598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
    Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
    EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
    Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
    Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
    Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
    Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
    Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
    Petersen MP; Möller S; Bygum A; Voss A; Bliddal M
    Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
    Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
    JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients.
    Masseran C; Perray L; Murat de Montai Q; Mathian A; Teboul A; Francès C; Arnaud L; Costedoat-Chalumeau N; Amoura Z; Courvoisier DS; Barbaud A; Chasset F
    J Am Acad Dermatol; 2024 Jun; 90(6):1210-1217. PubMed ID: 38301924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk in cutaneous lupus erythematosus: a population-based cohort study.
    Singh AG; Crowson CS; Singh S; Davis MD; Maradit-Kremers H; Matteson EL; Chowdhary VR
    Rheumatology (Oxford); 2016 Nov; 55(11):2009-2013. PubMed ID: 27520797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of cancer among 3663 patients with cutaneous lupus erythematosus: a Swedish nationwide cohort study.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2012 May; 166(5):1053-9. PubMed ID: 22175767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset cutaneous lupus erythematosus patients have distinctive clinical features and demographics versus early-onset patients.
    Anderson SR; Hynan LS; Chong BF
    Lupus; 2022 Oct; 31(12):1523-1528. PubMed ID: 35995793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
    Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
    Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    Yafasova A; Fosbøl EL; Schou M; Gustafsson F; Rossing K; Bundgaard H; Lauridsen MD; Kristensen SL; Torp-Pedersen C; Gislason GH; Køber L; Butt JH
    J Am Coll Cardiol; 2020 Aug; 76(7):767-777. PubMed ID: 32792073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyautoimmunity in patients with cutaneous lupus erythematosus: A nationwide sex- and age-matched cohort study from Denmark.
    Graven-Nielsen CS; Vittrup IV; Kragh AJ; Lund F; Bliddal S; Kofoed K; Kristensen S; Stensballe A; Nielsen CH; Feldt-Rasmussen U; Cordtz R; Dreyer L
    JAAD Int; 2023 Dec; 13():126-133. PubMed ID: 37808964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.